Division of WerfenLife Group SA
Latest From Accumetrics Inc.
This week's appointment roundup includes senior appointments by Promethera, HealthTell, Alzheon and Gilead Nordic with Baxter International, Therachon and Arena Pharmaceuticals making board appointments.
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced August through September 2013.
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced August-September 2013.
Study results on ICD programming, biventricular pacing and more from the 2012 AHA Scientific Sessions in Los Angeles.
In Vitro Diagnostics
- Therapeutic Drug Monitoring
- Therapeutic Areas
- Blood & Coagulation Disorders & Products
- Neurology, Nervous System
- North America
- Parent & Subsidiaries
- WerfenLife Group SA
- Senior Management
Timothy I Still, Pres. & CEO
Gregory J Tibbitts, CFO
Ad de Waard, VP, Int'l Sales & Mktg.
Andrew Chisholm, VP, Sales & Corp. Accounts
Jeffrey Dahlen, PhD, CSO
- Contact Info
Phone: (858) 643-1600
3985 Sorrento Valley Blvd.
San Diego, CA 92121
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.